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The bone-marrow microenviron-
ment supports the growth and differen-
tiation of many hematopoietic line-
ages, in addition to B-lymphocytes.
Primary bone-marrow cell cultures de-
signed to promote the development of
specific cell types in vitro are highly de-
sirable experimental systems,
amenable to manipulation under con-
trolled conditions. However, the dy-
namic and complex network of stromal
cells and insoluble matrix proteins is
disrupted in prior plate- and flask-
based culture systems, wherein the mi-
croenvironments have a predominantly
two-dimensional (2D) character. In 2D
bone-marrow cultures, normal B-lym-
phoid cells become progressively
skewed toward precursor B-cell popula-
tions that do not retain a normal im-
munophenotype, and such mature
B-lymphocytes as those harvested from
the spleen or lymph nodes do not sur-
vive beyond several days ex vivo in the
absence of mitogenic stimulation.
The present 3D culture system is a
bioreactor that contains highly porous ar-
tificial scaffolding that supports the
long-term culture of bone marrow,
spleen, and lymph-node samples. In this
system, unlike in 2D culture systems,
B-cell subpopulations developing within
3D cultures that have been modified to
foster lymphopoiesis retain an im-
munophenotype that closely recapitulates
cells in fresh bone marrow harvests. The
3D culture system has been found to be
capable of supporting long-lived (8
weeks) populations of B and T lympho-
cytes from peripheral lymphoid organs, in
the absence of activation signals, to an ex-
tent not achievable by conventional cul-
ture techniques. Interestingly, it has been
found that 3D-culture B cells display a
phenotype that has characteristics of both
B1a and B2 cells. These promising prelim-
inary observations suggest that the 3D cul-
ture system could be used with success in
the study of peripheral-B-lymphocyte biol-
ogy and in the development of biotechno-
logical techniques and processes.
This work was done by J. H. David Wu
and Andrea Bottaro of the University of
Rochester for Johnson Space Center. For fur-
ther information, contact the Johnson Com-
mercial Technology Office at (281) 483-3809.
In accordance with Public Law 96-517,
the contractor has elected to retain title to this
invention. Inquiries concerning rights for its
commercial use should be addressed to:
University of Rochester, Chemical Engineering
518 Hylan Building
P.O. Box 270140
Rochester, NY 14627-0140
Phone No.: (585) 275-3998
Web: www.rochester.edu/ott/
Refer to MSC-23571-1, volume and num-
ber of this Medical Design Briefs issue, and
the page number.
Tissuelike 3D Assemblies of Human Broncho-Epithelial Cells
Experimental conditions are more realistic than those of 2D monolayer cell cultures.
Lyndon B. Johnson Space Center, Houston, Texas
Three-dimensional (3D) tissuelike as-
semblies (TLAs) of human broncho-ep-
ithelial (HBE) cells have been developed
for use in in vitro research on infection of
humans by respiratory viruses. The 2D
monolayer HBE cell cultures heretofore
used in such research lack the complex
cell structures and interactions charac-
teristic of in vivo tissues and, conse-
quently, do not adequately emulate the
infection dynamics of in-vivo microbial
adhesion and invasion. In contrast, the
3D HBE TLAs are characterized by
more-realistic reproductions of the geo-
metrical and functional complexity, dif-
ferentiation of cells, cell-to-cell interac-
tions, and cell-to-matrix interactions
characteristic of human respiratory ep-
ithelia. Hence, the 3D HBE TLAs are ex-
pected to make it possible to perform at
least some of the research in vitro under
more-realistic conditions, without need
to infect human subjects.
The TLAs are grown on collagen-
coated cyclodextran microbeads under
controlled conditions in a nutrient liq-
uid in the simulated microgravitational
environment of a bioreactor of the ro-
tating-wall-vessel type. Primary human
mesenchymal bronchial-tracheal cells
are used as a foundation matrix, while
adult human bronchial epithelial im-
mortalized cells are used as the overly-
ing component. The beads become
coated with cells, and cells on adjacent
beads coalesce into 3D masses. The re-
sulting TLAs have been found to share
significant characteristics with in vivo
human respiratory epithelia including
polarization, tight junctions, desmo-
somes, and microvilli. The differentia-
tion of the cells in these TLAs into tis-
sues functionally similar to in vivo
tissues is confirmed by the presence of
These Virus Titers indicate rapid growth of virus populations during the first few days.
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tissuelike differentiation marker com-
pounds, including villin, keratins, and
specific lung epithelium marker com-
pounds, and by the production of tissue
mucin.
In a series of initial infection tests, TLA
cultures were inoculated with human res-
piratory syncytial viruses and parain-
fluenza type 3 viruses. Infection was con-
firmed by photomicrographs that showed
signs of damage by viruses and virus titers
(see figure) that indicated large increases
in the populations of viruses during the
days following inoculation.
This work was done by Thomas J. Good-
win of Johnson Space Center. Further in-
formation is contained in a TSP (see
page 1). 
This invention is owned by NASA, and a
patent application has been filed. Inquiries con-
cerning nonexclusive or exclusive license for its
commercial development should be addressed to
the Patent Counsel, Johnson Space Center,
(281) 483-0837. Refer to MSC-24164-1.
Isolation of Resistance-Bearing Microorganisms
NASA’s Jet Propulsion Laboratory, Pasadena, California
Strategies were explored for inactivat-
ing resistance-bearing microorganisms,
focusing on a new species (Bacillus hor-
neckii sp. nov.) discovered on the surfaces
of the Kennedy Space Center cleanroom
facility in which the Phoenix lander was
assembled. Two strains that belong to this
novel species were isolated and subjected
to a comprehensive, polyphasic analysis
to characterize their taxonomic position.
Both phenotypic and genotypic analy-
ses clearly indicate that these isolates be-
long to the genus Bacillus, and represent
a novel species. In addition to the phylo-
genetic affiliation, structurally the spores
of this novel bacterium possess an extra-
neous layer, which might be responsible
for increased resistance to space radia-
tion conditions. The chemical character-
ization of this novel, extraneous layer of
spores will reveal the mechanisms be-
hind radiation resistance.
This work was done by Kasthuri J.
Venkateswaran, Alexander Probst, Parag A.
Vaishampayan, and Sudeshna Ghosh of
Caltech; and Shariff Osman of Lawrence
Berkeley National Laboratory for NASA’s Jet
Propulsion Laboratory. For more informa-
tion, contact iaoffice@jpl.nasa.gov. NPO-
46337
To better exploit the principles of gas
transport and mass transport during
the processes of cell seeding of 3D scaf-
folds and in vitro culture of 3D tissue
engineered constructs, the oscillatory
cell culture bioreactor provides a flow
of cell suspensions and culture media
directly through a porous 3D scaffold
(during cell seeding) and a 3D con-
struct (during subsequent cultivation)
within a highly gas-permeable closed-
loop tube. This design is simple, modu-
lar, and flexible, and its component
parts are easy to assemble and operate,
and are inexpensive. Chamber volume
can be very low, but can be easily scaled
up. This innovation is well suited to
work with different biological speci-
mens, particularly with cells having
high oxygen requirements and/or
shear sensitivity, and different scaffold
structures and dimensions.
The closed-loop changer is highly gas
permeable to allow efficient gas ex-
change during the cell seeding/cultur-
ing process. A porous scaffold, which
may be seeded with cells, is fixed by
means of a scaffold holder to the cham-
ber wall with scaffold/construct orienta-
tion with respect to the chamber deter-
mined by the geometry of the scaffold
holder. A fluid, with/without biological
specimens, is added to the chamber such
that all, or most, of the air is displaced
(i.e., with or without an enclosed air bub-
ble). Motion is applied to the chamber
within a controlled environment (e.g.,
oscillatory motion within a humidified
37 ºC incubator). Movement of the
chamber induces relative motion of the
scaffold/construct with respect to the
fluid. In case the fluid is a cell suspen-
sion, cells will come into contact with the
scaffold and eventually adhere to it. Al-
ternatively, cells can be seeded on scaf-
folds by gel entrapment prior to bioreac-
tor cultivation.
Subsequently, the oscillatory cell cul-
ture bioreactor will provide efficient gas
exchange (i.e., of oxygen and carbon
dioxide, as required for viability of meta-
bolically active cells) and controlled lev-
els of fluid dynamic shear (i.e., as re-
quired for viability of shear-sensitive
cells) to the developing engineered tis-
sue construct.
This bioreactor was recently utilized
to show independent and interactive ef-
fects of a growth factor (IGF-I) and slow
bidirectional perfusion on the survival,
differentiation, and contractile perform-
ance of 3D tissue engineering cardiac
constructs. 
The main application of this system
is within the tissue engineering indus-
try. The ideal final application is within
the automated mass production of tis-
sue-engineered constructs. Target in-
dustries could be both life sciences
companies as well as bioreactor device
producing companies. 
This work was done by Lisa E. Freed,
Mingyu Cheng, and Matteo G. Moretti of
Massachusetts Institute of Technology for
Johnson Space Center. For further informa-
tion, contact the Johnson Technology Transfer
Office at (281) 483-3809. 
In accordance with Public Law 96-
517, the contractor has elected to retain
title to this invention. Inquiries concern-
ing rights for its commercial use should be
addressed to:
Patent Compliance Administrator
Massachusetts Institute of Technology
Five Cambridge Center, Kendall Square
Room NE25-230
Cambridge, MA 021142-1493
Refer to MSC-24270-1, volume and num-
ber of this Medical Design Briefs issue, and
the page number.
Oscillating Cell Culture Bioreactor
This bioreactor is well suited to work with different biological specimens.
Lyndon B. Johnson Space Center, Houston, Texas
